Skip to content
Insider tapeLive · 5:07 PM ET
My stocks

Henry Schein (HSIC) insider trading

Insider activity, historical context and SEC filings · data through Nov 20, 2026

Health CareMedical DistributionHSIC

Closing price · Nov 19, 2026 $83.95 -2.0% on the day · +18.9% over 12 months 52-week range $68.99 – $90.86
Get HSIC alerts
Open-market purchases1 insider$692K · last 12 months
Insiders selling5last 12 months
Reported sales$8.6M0 of 10 recent sales pre-planned (10b5-1)
In 15 seconds

Some insider buying ($692K), but sales were much larger ($8.6M) over the same 12 months.

Past insider buys here: 1 of 1 beat the S&P 500 over the next 90 days (small sample). See each one ↓

Label: Net selling · based on open-market trades (codes P and S), last 12 months. Not a rating or advice.
  • Next earnings expected around Feb 2, 2027 (estimate from past release dates). Insiders usually trade in the weeks after results; past reactions ↓
Latest open-market trade

Purchase William K. Daniel, Director bought 10,000 shares at $69.19 ($692K).

Trade date
May 11, 2026
Disclosed to the SEC
May 12, 2026
Type
Open-market purchase (code P)

Read the original SEC filing ↗All HSIC insider trades ↓

Insiders have two business days to report a trade to the SEC, so filings (and our alerts) always come after the trade, never in real time.

HSIC insider transactions (Form 4)

Open-market purchases and sales. 61 grants, option exercises and tax withholdings are not shown.

Filed Insider Type Shares Price Value Since Score
May 12SEC William K. DanielDirectorStake +100% Buy 10,00020,000 held (+100%) $69.19 $692K +21.3% —
Mar 20SEC Thomas C. PopeckCEO Sell 1,35586,182 held (−2%) $72.79 $99K +15.3% —
Mar 11SEC Kurt P. KuehnDirector Sell 2,84415,420 held (−16%) $78.96 $225K +6.3% —
Mar 6SEC Mark E. MlotekEvp, Chief Strategic Officer Sell 4,10082,379 held (−5%) $80.80 $331K +3.9% —
Mar 6SEC Philip A. LaskawyDirector Sell 2,84421,961 held (−11%) $80.36 $229K +4.5% —
Mar 6SEC Mark E. MlotekEvp, Chief Strategic Officer Sell 1,82580,554 held (−2%) $80.81 $147K +3.9% —
Mar 3SEC Stanley M. BergmanCEO, Chair Sell 23,858403,757 held (−6%) $81.31 $1.9M +3.2% —
Mar 3SEC Stanley M. BergmanCEO, Chair Sell 19,954383,803 held (−5%) $81.31 $1.6M +3.2% —
Feb 27SEC Stanley M. BergmanCEO, Chair Sell 31,134434,827 held (−7%) $80.90 $2.5M +3.8% —
Feb 27SEC Stanley M. BergmanCEO, Chair Sell 10,785309,092 held (−3%) $81.20 $876K +3.4% —
Feb 27SEC Stanley M. BergmanCEO, Chair Sell 7,212427,615 held (−2%) $81.51 $588K +3.0% —
Historical context

Similar past setups: not applicable. There aren't enough comparable past cases for HSIC's latest buying to report odds. When insiders buy, this section shows how 6,290 similar past buys did over 90 days. How we calculate this →

Play with HSIC in the Research Lab

Pre-set to HSIC's latest insider buy of $10K or more (May 12, 2026: William K. Daniel, $692K). Tap to change anything.

All tools →

Quick backtest: did buys like this beat the market?

Insiders buying
CEO or CFO
Dollar size
Stock before

Tap a setting to see how 6,290 past insider buys did.

Open the full Backtester →

Share price and insider trades

HSIC closeInsider buyInsider sale
60708090100DecJan 2026FebMarAprMayJunJulAugSepOctNovEEarnings release filed 2026-02-24EEarnings release filed 2026-05-05EEarnings release filed 2026-08-04EEarnings release filed 2026-11-03Sold $98,630 on 2026-03-19 · Thomas C. PopeckSold $224,565 on 2026-03-10 · Kurt P. KuehnSold $228,544 on 2026-03-05 · Philip A. LaskawySold $478,740 on 2026-03-04 · Mark E. MlotekBought $691,900 on 2026-05-11 · William K. DanielSold $875,742 on 2026-02-27 · Stanley M. BergmanSold $3,106,591 on 2026-02-26 · Stanley M. BergmanSold $3,562,354 on 2026-03-02 · Stanley M. Bergman
Bought, 12 months$692K
Sold, 12 months$8.6M
Insiders buying1
Insiders selling5

Henry Schein insider trading at a glance (Nov 20, 2026): in the past 12 months, 1 insider bought $692K and 5 sold $8.6M of HSIC stock on the open market; P/E 23.1 vs. a sector median of 25.0.

By InsiderPrint Research Desk · Updated · Sources: SEC EDGAR Form 4 filings, FINRA short-sale volume · How we calculate this

HSIC insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q1 2026: $8.6M sold (10 trades)Q1 2026Q2 2026: $692K bought (1 trades)$692KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$692K1—0
Q1 2026—0$8.6M10

Valuation, profit and volume

P/E (trailing)23.1Sector median 25.0
Market value$9.33BMedical Distribution
Profit margin3.1%Revenue growth +4.0%
Volume vs. 50-day1.2×Last 5 sessions
Insiders' paper profit+$148KOn all tracked purchases +21.3%

Source: Yahoo Finance, as of Nov 16, 2026. Volume and paper profit use daily closing prices.

Summary

Over the past 12 months, 1 Henry Schein insider reported open-market purchases totaling $692K, while 5 insiders reported sales totaling $8.6M. Among insiders with enough purchase history to measure, Robert J. Hombach (Director) has the highest Insider Score at 79. 0 of 10 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

HSIC earnings: how the stock reacted

Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.

Does it matter? →
Release15 days beforeInsiders, 30 days beforeReaction (2 days)Next 30 days
Nov 3, 2026 +0.3% None +1.9%S&P +2.0% pending
Aug 4, 2026 -1.5% None +3.6%S&P +1.6% +0.2%
May 5, 2026 -8.6% None +0.6%S&P +2.2% +6.9%
Feb 24, 2026 +1.1% None +1.7%S&P +1.6% -12.0%
Nov 4, 2025 +2.6% None +11.4%S&P -0.8% +2.2%
Aug 5, 2025 +1.3% None -5.3%S&P +0.3% +4.7%
May 5, 2025 +0.9% None +1.4%S&P -1.4% +6.4%
Feb 25, 2025 -1.7% None -6.6%S&P -0.4% -5.4%

Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.

HSIC short selling

Daily short-sale volume as a share of trading volume (FINRA), with the 20-day average.

20%40%60%2026-08-26: 79% of volume sold short2026-08-27: 62% of volume sold short2026-08-28: 73% of volume sold short2026-08-31: 62% of volume sold short2026-09-01: 63% of volume sold short2026-09-02: 43% of volume sold short2026-09-03: 71% of volume sold short2026-09-04: 82% of volume sold short2026-09-08: 68% of volume sold short2026-09-09: 60% of volume sold short2026-09-10: 73% of volume sold short2026-09-11: 75% of volume sold short2026-09-14: 75% of volume sold short2026-09-15: 78% of volume sold short2026-09-16: 72% of volume sold short2026-09-17: 70% of volume sold short2026-09-18: 48% of volume sold short2026-09-21: 27% of volume sold short2026-09-22: 47% of volume sold short2026-09-23: 50% of volume sold short2026-09-24: 64% of volume sold short2026-09-25: 46% of volume sold short2026-09-28: 48% of volume sold short2026-09-29: 53% of volume sold short2026-09-30: 59% of volume sold short2026-10-01: 65% of volume sold short2026-10-02: 71% of volume sold short2026-10-05: 68% of volume sold short2026-10-06: 65% of volume sold short2026-10-07: 69% of volume sold short2026-10-08: 76% of volume sold short2026-10-09: 67% of volume sold short2026-10-12: 68% of volume sold short2026-10-13: 78% of volume sold short2026-10-14: 67% of volume sold short2026-10-15: 57% of volume sold short2026-10-16: 54% of volume sold short2026-10-19: 68% of volume sold short2026-10-20: 33% of volume sold short2026-10-21: 53% of volume sold short2026-10-22: 35% of volume sold short2026-10-23: 46% of volume sold short2026-10-26: 59% of volume sold short2026-10-27: 62% of volume sold short2026-10-28: 47% of volume sold short2026-10-29: 52% of volume sold short2026-10-30: 42% of volume sold short2026-11-02: 33% of volume sold short2026-11-03: 23% of volume sold short2026-11-04: 20% of volume sold short2026-11-05: 35% of volume sold short2026-11-06: 48% of volume sold short2026-11-09: 39% of volume sold short2026-11-10: 48% of volume sold short2026-11-11: 66% of volume sold short2026-11-12: 57% of volume sold short2026-11-13: 35% of volume sold short2026-11-16: 68% of volume sold short2026-11-17: 48% of volume sold short2026-11-18: 41% of volume sold shortAug 26Sep 10Sep 24Oct 8Oct 22Nov 5
Latest (Nov 18): 41%20-day average: 38%Prior 2 months: 62%

This is short volume from off-exchange trades, not short interest. It includes market makers' routine hedging, so 40–50% is normal; what stands out is a ratio well above the stock's own average. Insiders buying while shorts pile in →

What happened after HSIC insiders bought

Each open-market purchase, measured from the day the filing became public, next to the S&P 500 over the same days. Losses included; "pending" means the days haven't passed yet.

Across all stocks →
FiledInsiderBought7 days30 days90 days
May 12, 2026William K. DanielDirector$692K +5.1%+5.8% vs S&P+15.7%+15.7% vs S&P+27.0%+22.0% vs S&P

Insiders at Henry Schein

InsiderBoughtSoldLast filingPast buys beat S&PScore
Stanley M. BergmanFormer Director — $7.5M May 26, 2026 — —
William K. DanielDirector $692K — Jun 15, 2026 — —
Mark E. MlotekEvp, Chief Strategic Officer — $479K Mar 17, 2026 — —
Philip A. LaskawyDirector — $229K Mar 9, 2026 — —
Kurt P. KuehnDirector — $225K Mar 11, 2026 — —
Thomas C. PopeckCEO — $99K Mar 20, 2026 — —
Andrea AlbertiniCEO — — Sep 9, 2026 — —
Ronald N. SouthCFO — — Mar 17, 2026 — —
Michael S. EttingerCOO — — Mar 17, 2026 — —
Christine Zayac SheehySvp, Chief Human Res. Officer — — Mar 17, 2026 — —
Frederick M. LoweryCEO — — Mar 10, 2026 — —
Bradley T. ShearesDirector — — Mar 9, 2026 — —
Joseph L. HerringDirector — — Mar 9, 2026 — —
Deborah DerbyDirector — — Mar 9, 2026 — —
Robert J. HombachDirector — — Mar 9, 2026 — 79
Reed Vaughn TucksonDirector — — Mar 9, 2026 — —
Mohamad AliDirector — — Mar 9, 2026 — —
Anne H. MarguliesDirector — — Mar 9, 2026 — —
Carole T. FaigDirector — — Mar 9, 2026 — —
Scott Philip SerotaDirector — — Mar 9, 2026 — —

Board links: companies that share insiders with HSIC

Directors and executives who filed Form 4s for HSIC and another company in the last 12 months.

See the map →

Insider activity at other Health Care companies

Same sector, ranked by insider buying in the last 90 days.

  • KODKodiak Sciences Inc.$181M bought
  • BBTXBambusa Therapeutics, Inc.$52.6M bought
  • WWBWINDWARD BIO GROUP AG$49.8M bought
  • ADRXADARx Pharmaceuticals, Inc.$43.4M bought
  • PEPGPepGen Inc.$43.1M bought
  • LYCALycia Therapeutics, Inc.$38.5M bought

HSIC stock: common questions

Are Henry Schein insiders buying HSIC stock?

In the past 12 months, 1 insider reported open-market purchases of HSIC worth $692K. The latest was Director William K Daniel bought $692K of HSIC at $69.19 — first open-market purchase in our records; raises the stake by 100%.

Are Henry Schein insiders selling HSIC stock?

5 insiders reported sales worth $8.6M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is HSIC's P/E ratio?

HSIC trades at about 23.1 times trailing earnings, compared with a median of 25.0 for the Health Care sector.

What is HSIC's 52-week range?

Over the past year HSIC has traded between $68.99 and $90.86. It last closed at $83.95 on Nov 19, 2026.